Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Down 35.3% in May

Clearmind Medicine Inc. (NASDAQ:CMND) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 105,700 shares, a decrease of 35.3% from the May 15th total of 163,300 shares. Based on an average daily volume of 239,000 shares, the short-interest ratio is currently 0.4 days. Approximately 3.6% of the shares of the company are sold short.

Clearmind Medicine Price Performance

Shares of CMND remained flat at $0.87 on Tuesday. The company had a trading volume of 8,620 shares, compared to its average volume of 857,365. The company’s fifty day moving average is $0.97 and its 200-day moving average is $1.19. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a market cap of $3.71 million, a price-to-earnings ratio of -0.46 and a beta of 0.91. Clearmind Medicine has a 1-year low of $0.80 and a 1-year high of $2.30.

Clearmind Medicine (NASDAQ:CMND) last released its quarterly earnings results on Thursday, June 12th. The company reported ($0.16) earnings per share for the quarter.

Hedge Funds Weigh In On Clearmind Medicine

An institutional investor recently bought a new position in Clearmind Medicine stock. Virtu Financial LLC bought a new stake in Clearmind Medicine Inc. (NASDAQ:CMND) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 39,479 shares of the company’s stock, valued at approximately $54,000. Virtu Financial LLC owned 0.92% of Clearmind Medicine at the end of the most recent quarter. 96.05% of the stock is currently owned by institutional investors and hedge funds.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.